PHARMACEUTICAL MANUFACTURING LICENSING & SETUP
Start a pharmaceutical manufacturing business in Australia
HCPA helps you define your manufacturing scope, establish the facility and GMP systems and prepare for TGA licensing and inspection.

Pharmaceutical manufacturing can cover a wide range of activities, from packaging and labelling through to more complex production processes. The first step is defining exactly what you intend to manufacture and which activities your facility will perform. That scope matters because your TGA manufacturing licence is tied to the manufacturing activities approved for your site, and those activities influence the facility, equipment, validation, personnel and quality systems you need.
HCPA can help you map these requirements early and build a clearer pathway from facility planning through to licence application and inspection readiness.
Still deciding whether pharmaceutical manufacturing is the right opportunity for you?
HCPA can help you assess the manufacturing model, likely investment, customer demand and regulatory requirements before you commit significant capital to a facility, equipment or production capability.
If you decide to proceed, we can then help you move from planning into facility and GMP development, licensing and TGA inspection readiness.
Who can become a pharmaceutical manufacturer?
Pharmaceutical manufacturing can suit businesses with different starting points and manufacturing models. The right pathway will depend on the products or services you intend to offer, your facility, technical capability and the manufacturing activities you plan to undertake.
What do you need to become a pharmaceutical manufacturer in Australia?
Australian manufacturers of medicines, active pharmaceutical ingredients and certain other therapeutic goods generally need a TGA manufacturing licence.
Getting licensed involves more than submitting an application. Your facility, equipment, people and quality systems need to be sufficiently established for the TGA to assess how the operation will work in practice.

1. Manufacturing scope and licensing
Australian manufacturers of medicines, active pharmaceutical ingredients and certain other therapeutic goods generally need a TGA manufacturing licence.
Your first step is to define exactly what the site will manufacture and which activities it will perform. This can range from packaging and labelling through to more complex production and directly affects the scope of the licence.
Your proposed scope also determines many of the facility, equipment, quality, validation and personnel requirements that follow.
HCPA can help define the manufacturing scope and licensing pathway before significant resources are committed.
2. Facility, equipment and validation
Your premises, equipment and utilities need to support the products and manufacturing processes involved. Depending on the operation, this may include:
- production and storage areas
- appropriate material and personnel flows
- environmental controls
- cleaning systems
- manufacturing equipment and utilities
- qualification of facilities and equipment
- validation of relevant manufacturing processes
A new greenfield facility is not always required. Depending on the activities involved, an existing facility may be adapted, although its layout, equipment, utilities and controls need to support the proposed GMP requirements.
Planning these requirements early can reduce the risk of investing in a facility or equipment that is not suitable for the intended manufacturing scope.
3. GMP systems and personnel
Before inspection, you need a documented and implemented quality system covering areas such as:
- documentation and records
- deviations and change control
- manufacturing and batch records
- qualification and validation
- staff training
- quality control
- complaints and recalls
- release for supply
You also need appropriately qualified manufacturing and quality personnel who understand their responsibilities. The expertise required will depend on the scale, products and complexity of the operation.
HCPA can help develop the GMP systems and documentation around your proposed manufacturing model and identify where additional technical expertise may be required.
4. Application, inspection, timeframes and costs
The TGA has a licensing process for Australian pharmaceutical manufacturers.
In broad terms, you need to:
- confirm the manufacturing activities and site covered by the application
- prepare the facility, quality systems, equipment, validation and personnel
- submit the manufacturing licence application
- undergo a TGA GMP inspection
- address any findings before the TGA makes its licensing decision
Your operation needs to be sufficiently established for the TGA to assess how it will work in practice, so inspection readiness is an important part of the application process.
There is no single end-to-end timeframe or cost for establishing a pharmaceutical manufacturing operation. The investment and preparation required will depend heavily on the products, manufacturing scope and facility model.
Costs can include:
- facility construction or modification
- manufacturing equipment and utilities
- qualification and validation
- quality systems and documentation
- technical and quality personnel
- TGA application and inspection fees
- raw materials and packaging
- testing and inventory
- working capital
- specialist architectural, engineering or validation support
A packaging operation in an adapted facility can have a very different cost and preparation pathway from a purpose-built production facility.
Complex projects may require GMP and regulatory consultants to work alongside specialist architects, engineers, equipment providers and validation experts. For new, significantly modified or complex facilities, a TGA GMP pre-submission meeting may also help clarify the proposed scope and application pathway.
HCPA can support you from defining the licence scope and coordinating regulatory requirements through to quality-system development and inspection readiness.
Why work with HCPA when starting a pharmaceutical manufacturing business?
Pharmaceutical manufacturing is easier to navigate when the commercial model, manufacturing scope, facility and GMP requirements are planned together from the outset.
It is never too early to speak with HCPA. Whether you are still assessing the opportunity or ready to begin developing the operation, we can help you understand the commercial, operational and regulatory requirements and plan the right pathway forward.
HCPA helps you understand what needs to be licensed, what needs to be established and what the operation will need to demonstrate to the TGA before inspection.
How HCPA helps you become a pharmaceutical manufacturer
Define your manufacturing scope
We review your products, proposed activities and facility model to identify the manufacturing scope and regulatory pathway that apply.
Establish your GMP requirements
We map the facility, equipment, personnel, quality-system, qualification and validation requirements around the proposed manufacturing activities.
Prepare your systems and application
HCPA helps develop the quality systems and documentation, organise the licensing application and identify gaps before TGA inspection.
Prepare for TGA inspection
We help you get inspection-ready, respond to findings where required and move through the licensing process towards operation.
Our experience helping businesses enter regulated markets
businesses supported
consultants
first-time approval rate
client revenue generated
HCPA has extensive experience helping businesses enter regulated markets, understand approval requirements and establish the operational foundations needed to move from opportunity to market entry.
For pharmaceutical manufacturers, we apply that regulatory and operational experience to manufacturing scope, GMP systems, documentation, validation planning and inspection readiness, helping create a clearer pathway from concept to a licence-ready operation.
Frequently asked questions about starting a pharmaceutical manufacturing business
Is pharmaceutical manufacturing a viable business opportunity in Australia?
It can be where there is sufficient demand for the product or manufacturing capability and the expected revenue can support the investment required to establish and operate the facility.
The opportunity will depend on the manufacturing model, target customers, production volumes, capacity utilisation, pricing, margins and regulatory requirements.
HCPA can help you assess these factors together before significant capital is committed.
What are the major startup costs involved in establishing a pharmaceutical manufacturing company?
Major costs can include facility construction or modification, manufacturing equipment and utilities, qualification and validation, quality systems, technical expertise, staffing, regulatory fees, raw materials and working capital.
The amount varies significantly by manufacturing model. A packaging operation in an adapted facility can have very different capital requirements from a complex purpose-built manufacturing site.
How can I assess whether a pharmaceutical manufacturing model is commercially viable?
Start by defining the product or manufacturing capability, the customers likely to need it and how the business will generate revenue.
Then assess realistic demand, production volumes, capacity utilisation, pricing and margins against the investment and operating costs required.
The goal is to determine whether the expected commercial return justifies establishing the manufacturing capability.
What should a pharmaceutical manufacturing business model include?
Your business model should bring together:
- target products or manufacturing services
- target customers and demand
- production volumes and capacity
- pricing and margins
- facility and equipment investment
- staffing and quality requirements
- regulatory costs
- working capital
- timeframe to operation
Bringing these factors together helps you assess the opportunity against what it will actually take to establish and operate the business.
Is contract pharmaceutical manufacturing a viable business model?
It can be where there is sufficient demand for the manufacturing capability and enough recurring production volume to support the facility and operating costs.
Assess likely contract values, margins, capacity utilisation and the investment required to establish the capability before proceeding.
How long can it take to establish a pharmaceutical manufacturing facility?
There is no standard timeframe.
A relatively straightforward operation using an adaptable existing facility can have a very different pathway from a complex greenfield project requiring substantial design, engineering, installation, qualification and validation before licensing.
What is the process for obtaining a TGA manufacturing licence in Australia?
Australian pharmaceutical manufacturers generally need to define their manufacturing scope, prepare the facility and GMP systems, submit the licence application and undergo a TGA inspection.
Any deficiencies identified during the inspection need to be addressed before the licensing process can be finalised.
HCPA can help you prepare the operation and navigate the licensing and inspection process.
Who can help design the facility, quality systems and documentation needed to establish a compliant pharmaceutical manufacturing operation?
A pharmaceutical manufacturing project may require regulatory, quality, architectural, engineering and validation expertise.
HCPA can define the GMP and regulatory requirements, develop quality systems and documentation and prepare the operation for licensing and inspection. Specialist architects, engineers and technical providers may also be required for more complex facility and equipment projects.
Do all pharmaceutical manufacturers need a TGA manufacturing licence?
Australian manufacturers of medicines, APIs and certain other therapeutic goods generally require a TGA manufacturing licence unless an exemption applies.
The requirements depend on the therapeutic goods and manufacturing activities involved, so the pathway should be confirmed before proceeding.
Is packaging considered pharmaceutical manufacturing?
It can be. Packaging and labelling can constitute steps in the pharmaceutical manufacturing process, depending on the product and activity involved.
This means a business undertaking packaging activities may still need to consider relevant TGA licensing and GMP requirements.
Does a pharmaceutical manufacturing facility need to be newly built?
No. A new greenfield facility is not always required.
Depending on the proposed manufacturing activities, an existing facility may be adapted to meet the relevant pharmaceutical manufacturing requirements.
The feasibility of doing so depends on factors such as facility layout, equipment, utilities, environmental controls, validation and the products being manufactured.
What needs to be ready before the TGA inspection?
The facility and quality systems need to be sufficiently established for the TGA to assess the proposed operation in practice.
This generally includes an implemented quality system, appropriately qualified facilities and equipment, validation plans, and trained manufacturing and quality personnel.
Does my TGA manufacturing licence cover every type of pharmaceutical manufacturing?
No. The manufacturing activities included in your application determine the scope assessed by the TGA.
If you later want to undertake additional manufacturing activities, you may need to vary the scope of the licence.
Can I speak to the TGA before applying?
Yes. The TGA offers GMP pre-submission meetings for circumstances such as new or significantly modified facilities, first-time applicants, complex operations or uncertainty about the proposed manufacturing scope.
What happens if the TGA identifies deficiencies during the inspection?
The TGA will provide findings that need to be addressed within specified timeframes. The response required depends on the nature and significance of the deficiencies.
For serious findings, the focus shifts to investigation, CAPA and formal remediation.
Related pharmaceutical importing resources
Managingongoing compliance
Need help keeping your manufacturing operation compliant?
Growing your manufacturing business
Ready to grow your pharmaceutical manufacturing business?
Identify suitable clients, strengthen your market proposition and pursue partnerships and supply contracts that fit your manufacturing capabilities and support sustainable growth.
Start growingWhat Our Clients Say

